ESMO Rare Cancers

Led by Co Editors-in-Chief Armelle Dufresne and Timothée Olivier, ESMO Rare Cancers is our new open access journal.

It is the European Society for Medical Oncology's latest peer-reviewed open access journal. A new platform for the dissemination of high-quality research, clinical experiences, and multidisciplinary discussions aimed at improving the diagnosis, treatment, and overall outcomes of patients with rare and understudied malignancies.

Access the journal

Rare Cancers encompass a wide spectrum of malignancies characterized by a low incidence rate. These cancers pose unique challenges due to their limited prevalence, leading to gaps in knowledge, diagnosis, and therapeutic strategies. The journal focuses on diseases with an incidence of less than 6 cases per 100,000 individuals per year, defined by histology, molecular hallmarks or other criteria. Solid cancers, haematological malignancies, of children and adults are considered for publication.

ESMO Rare Cancers welcomes submissions across various domains, including but not limited to:

• Epidemiology and Surveillance: Investigations into the incidence, prevalence, and risk factors associated with rare cancers.
• Diagnostic Advancements: Novel approaches and technologies for early detection and accurate diagnosis.
• Treatment Modalities: Clinical trials, therapeutic innovations, and management strategies specific to rare cancer types.
• Patient Care and Quality of Life: Studies addressing supportive care, survivorship, and psychosocial aspects of rare cancer patients.
• Biomarkers and Precision Medicine: Identification of biomarkers and personalized treatment approaches.
• Genomics and Pathogenesis: Research on the genetic basis and molecular mechanisms underlying rare cancers.
• Multidisciplinary Collaboration: We encourage contributions from diverse healthcare professionals, including oncologists, pathologists, radiologists, surgeons, epidemiologists, and allied healthcare experts. Collaborative research, which combines various disciplines, is essential for a comprehensive understanding of rare cancers and the development of effective treatment strategies.
• Clinical Case Reports: The journal provides a platform for the publication of clinical case reports that offer valuable insights into rare cancer cases, unique diagnostic dilemmas, and innovative treatment approaches.
• Patient-Centred Focus: Recognizing the significance of the patient perspective, we promote the submission of articles that share patient experiences, challenges, and advocacy efforts, emphasizing the importance of patient-centred care in the rare cancer community.